Abstract
OBJECTIVES The objective of this study was to evaluate the acceptability and efficacy of an online dementia prevention intervention based on a cognitive behavioral shared decision-making model.
DESIGN This was an unblinded pilot study in which participants were randomly assigned to one of two treatment groups.
SETTING This study was carried out remotely via telephone, video conferencing and online data collection.
PARTICIPANTS Persons 50 years of age and older interested in developing more brain healthy lifestyles were recruited.
INTERVENTION Both groups received 12 weekly sessions on lifestyle factors related to cognitive decline. The treatment as usual (TAU) group received the information and was encouraged to make lifestyle changes. The cognitive behavioral shared decision-making model (CBSDM) group received structured weekly sessions with support for evidence-informed personal goal choices and behavior change strategies.
MEASUREMENTS Primary outcome measures were the Alzheimer Disease Risk Inventory and the Memory Self-Efficacy and Dementia Knowledge Assessment Scales. Participants reported brain health activities during the first, sixth, and 12th weeks of the study.
RESULTS The intervention was viewed positively by participants who all said they would participate in it again. Participants in the CBSDM group showed increases in knowledge of dementia risk factors and in exercise. Other outcomes were consistent with moderate to large effect sizes for both groups.
CONCLUSIONS An online intervention providing psychoeducation and behavior change support was viewed positively by older adults. Results provides preliminary support for the CBSDM intervention’s efficacy in promoting brain health in older adults. (243 words)
Registered at clinicaltrials.gov NCT04822129
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04822129
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of Nova Southeastern University gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
